ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Lifts Partial Clinical Hold on Phase 3 Study of Venetoclax americanpharmaceuticalreview
June 26, 2019AbbVie announced the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold placed on CANOVA (M13-494), a Phase 3 trial evaluating venetoclax (VENCLEXTA? OR VENCLYXTO?) for the investigational treatment of relapsed/refractory multipl
Pharma Sources Insight January 2025
